≡ Risteys
FG R12 + FR

Documentation Changelog GitHub Contact & Feedback

Dysplastic lesion of unknown severity in the cervix uteri, vagina or vulva

Endpoint Browser PheWeb

N14_FEMALE_GENITAL_DYSPLASIA_NOS

Endpoint definition

↥

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

only females

293373

2. Check conditions

None

293373

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

2 out of 7 registries used, show all original rules.

461

4. Check minimum number of events

None

461

5. Include endpoints

None

461

6. Filter based on genotype QC (FinnGen only)

461

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

First used in FinnGen datafreeze
DF7

Similar endpoints

↥

List of similar endpoints to Dysplastic lesion of unknown severity in the cervix uteri, vagina or vulva based on the number of shared cases.

Venn diagram with an highlighted set fully inside another set Similar with more cases:

Venn diagram with a set fully inside an highlighted set Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 2793 2793 -
Only index persons 2743 2743 -
Unadjusted period prevalence (%)
Whole population 0.08 0.08 -
Only index persons 0.10 0.10 -
Median age at first event (years)
Whole population - 41.62 -
Only index persons - 41.33 -

-FinnGen-

Key figures

All Female Male
Number of individuals 461 461 -
Unadjusted period prevalence (%) 0.16 0.16 -
Median age at first event (years) 43.10 43.10 -

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

No data

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
412
Matched controls
4120
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
N87.9
ICD-10 Finland
Dysplasia of cervix uteri, unspecified
5895.5
323.0
339
*
ULA02
NOMESCO Finland
Kolposcopy
20.9
157.4
288
411
LDA20
NOMESCO Finland
Biopsy of vaginal cervix
14.5
107.5
208
270
LDC03
NOMESCO Finland
Conisation of cervix uteri using diathermy or laser
16.4
93.5
163
158
R87.6
ICD-10 Finland
Abnormal findings in specimens from female genital organs, abnormal cytological findings
10.4
92.5
224
424
XLD00
NOMESCO Finland
Sytologyspecimen from mouth of uterus
9.9
91.2
230
465
LDA10
NOMESCO Finland
Curettage of cervix uteri
11.4
59.9
121
145
N87.0
ICD-10 Finland
Mild cervical dysplasia
12.9
45.0
83
79
N87.2
ICD-10 Finland
Severe cervical dysplasia, not elsewhere classified
12.8
42.3
78
74
N90.3
ICD-10 Finland
Dysplasia of vulva, unspecified
+∞
41.3
39
*
N89.3
ICD-10 Finland
Dysplasia of vagina, unspecified
+∞
37.0
35
*
8077/2-C53.9
ICD-O-3
Squamous intraepithelial neoplasia, high grade of cervix uteri
14.2
33.0
57
46
N87.1
ICD-10 Finland
Moderate cervical dysplasia
8.2
25.1
58
81
LC2BE
NOMESCO Finland
Transvaginal ultrasound examination of uterus, parametria and lower abdomen
2.7
20.5
232
1334
LFB00
NOMESCO Finland
Biopsy of vulva or perineum
7.8
18.9
44
62
A63.0
ICD-10 Finland
Anogenital (venereal) warts
5.2
17.1
55
119
LEB00
NOMESCO Finland
Biopsy of vagina
7.3
14.6
35
52
N90.2
ICD-10 Finland
Severe vulvar dysplasia, not elsewhere classified
51.7
12.9
15
*
LFC00
NOMESCO Finland
Partial excision of vulva
26.8
9.9
13
5
R87.9
ICD-10 Finland
Abnormal findings in specimens from female genital organs, unspecified abnormal finding
22.3
9.4
13
6
LCA06
NOMESCO Finland
Biopsy of endometrium
2.3
9.1
90
440
D06.0
ICD-10 Finland
Carcinoma in situ: Endocervix
24.6
9.0
12
5
N90.0
ICD-10 Finland
Mild vulvar dysplasia
22.5
8.1
11
5
D07.1
ICD-10 Finland
Carcinoma in situ: Vulva
45.9
7.7
9
*
LDB20
NOMESCO Finland
Electrocoagulation or laser therapy of cervix uteri
8.1
7.2
15
19
P01AB01
ATC
metronidazole; oral, rectal
1.8
7.1
196
1403
ZXC00
NOMESCO Finland
Use of diathermy
9.0
7.1
14
16
SPAT1193
SPAT
Pap smear
2.1
6.8
78
406
WX702
NOMESCO Finland
Supraglottic ventilation device
3.2
6.8
34
112
8140/2-C53.9
ICD-O-3
Adenocarcinoma in situ, NOS, of cervix uteri
22.9
6.7
9
*
X86
ICPC
Abnormal cervix smear
6.4
6.5
16
26
8071/2-C51.9
ICD-O-3
Differentiated intraepithelial neoplasia of vulva, NOS
70.9
6.4
7
*
LCD31
NOMESCO Finland
Radical laparoscopic hysterectomy
27.1
6.2
8
*
N89.1
ICD-10 Finland
Moderate vaginal dysplasia
27.1
6.2
8
*

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3025130) Human papilloma virus identified in Specimen
96
118
10.01
75.50
2.3
1.8
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
138
270
6.87
71.96
2.3
1.5
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
240
1248
2.93
28.30
2.5
1.5
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
14
45
3.18
3.68
1.6
1.3
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
177
1381
1.46
3.65
4.0
4.0
g/l
35.9
36.6
1.06
167
1286
(3019897) Erythrocyte distribution width [Ratio] by Automated count
19
77
2.53
3.34
1.7
2.0
%
13.0
13.3
0.61
19
77
(40768804) Tissue Pathology biopsy report
213
1748
1.41
3.22
2.9
2.0
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
145
1113
1.44
3.18
2.6
2.2
u/l
54.5
56.4
0.33
135
1039
(3037522) Nuclear Ab [Titer] in Serum
90
628
1.54
3.16
1.4
1.4
titre
642.2
563.3
0.10
18
144
(3009261) Glucose [Presence] in Urine by Test strip
235
1966
1.40
3.16
3.6
3.2
estimate
0.0
0.0
0.80
46
377
(3035350) Ketones [Presence] in Urine by Test strip
231
1930
1.39
3.11
3.7
3.2
estimate
0.0
0.0
0.00
45
379
(4035726)
50
307
1.71
2.95
1.4
1.4
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
112
831
1.46
2.92
3.7
3.3
kg/l
1.0
1.0
1.10
18
108
(3021601) Nitrite [Presence] in Urine by Test strip
231
1944
1.38
2.91
5.0
4.4
estimate
0.0
0.0
0.50
45
387
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
60
390
1.62
2.85
2.0
2.2
umol/l
5.2
5.2
0.00
47
335
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
111
827
1.45
2.82
1.3
1.3
iu/ml
17.5
29.4
1.33
41
292
(3016650) Hepatitis A virus Ab [Presence] in Serum
15
63
2.43
2.49
1.0
1.1
—
—
—
0
0
(3018418) pH of Serum or Plasma
127
991
1.39
2.47
4.2
3.4
ph
7.4
7.4
1.16
13
190
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
184
1523
1.35
2.47
3.8
3.2
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
196
1638
1.34
2.46
5.2
5.2
mmol/l
1.2
1.2
0.01
170
1383
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
159
1290
1.35
2.42
4.2
2.9
u/l
32.7
27.9
0.62
151
1235
(3029937) Albumin [Presence] in Urine by Test strip
131
1031
1.38
2.41
3.8
3.4
estimate
0.0
0.0
1.08
45
387
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
22
406
0.52
2.41
3.0
3.6
%
29.6
33.2
—
9
288
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
9
28
3.26
2.32
1.9
1.6
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
35
209
1.73
2.31
1.8
1.5
—
—
—
0
0
(4010399)
38
236
1.66
2.19
1.5
1.4
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
27
152
1.82
2.17
1.1
1.2
—
—
—
0
0
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
6
14
4.33
2.15
1.2
1.1
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
109
848
1.37
2.14
3.7
3.1
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
321
2917
1.33
2.10
4.1
3.9
mm/h
10.2
10.1
0.10
301
2719
(3013512) EKG study
65
887
0.69
2.07
2.5
3.0
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
214
1852
1.29
1.97
4.9
5.3
umol/l
10.0
9.4
0.59
201
1745
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
43
284
1.57
1.96
2.0
2.2
g/l
0.2
0.2
0.03
38
272
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
344
3677
0.75
1.95
10.1
9.3
ml/min/173m2
90.2
88.8
0.69
263
2963
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
46
310
1.54
1.92
1.5
1.7
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
24
398
0.58
1.85
2.1
1.8
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
312
2847
1.30
1.85
7.2
6.6
u/l
72.3
74.1
0.41
294
2675
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
46
313
1.52
1.85
1.5
1.7
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
68
501
1.42
1.83
3.5
2.3
e6/l
1.1
1.0
0.16
46
262
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
47
322
1.51
1.83
2.6
3.6
pmol/l
4.6
4.6
0.07
40
287
(3002032) Base excess in Venous blood by calculation
34
216
1.62
1.82
4.2
3.0
mmol/l
2.1
2.3
0.23
27
171
(1001926) Buprenorphine [Presence] in Urine by Screen method
7
168
0.41
1.82
1.4
1.4
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
89
689
1.36
1.80
1.7
1.6
pmol/l
455.8
46218925.0
1.31
79
595
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
13
60
2.20
1.79
5.8
2.2
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
18
95
1.93
1.78
1.4
1.4
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
21
117
1.83
1.77
4.1
8.5
—
—
—
0
0
(3028026) IgM [Mass/volume] in Serum or Plasma
36
235
1.58
1.74
1.7
1.7
g/l
1.3
1.4
0.31
31
216
(3000093) Morphology [Interpretation] in Blood Narrative
6
19
3.19
1.66
1.2
1.2
—
—
—
0
0
(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood
7
25
2.83
1.65
3.6
2.0
e6/l
472.9
488.5
—
7
20
(3026008) Bacteria identified in Urine by Culture
136
1132
1.29
1.65
3.0
2.5
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
103
826
1.32
1.64
1.3
1.3
u/ml
21.2
15.2
0.22
38
349
(3019225) pH of Specimen
18
310
0.56
1.61
3.0
3.4
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
11
214
0.50
1.47
1.3
1.4
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
61
460
1.38
1.46
1.6
1.8
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
11
52
2.14
1.45
1.4
1.4
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
12
59
2.06
1.44
1.1
1.1
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
11
212
0.51
1.44
1.3
1.4
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
28
181
1.58
1.43
3.3
2.4
ug/l
2.6
4.5
1.15
28
159
(3015736) pH of Urine
174
1514
1.24
1.42
3.7
3.0
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
11
211
0.51
1.42
1.3
1.4
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
11
211
0.51
1.42
1.3
1.4
—
—
—
0
0
(4062490)
9
40
2.27
1.41
1.2
1.4
—
—
—
0
0
(3024980) IgG subclass 4 [Mass/volume] in Serum
12
60
2.03
1.39
1.4
1.8
g/l
0.8
0.7
—
7
44
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
16
272
0.57
1.39
1.6
1.4
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
54
403
1.39
1.38
1.4
1.5
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
10
196
0.50
1.38
1.3
1.4
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
16
271
0.58
1.37
1.6
1.4
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
16
271
0.58
1.37
1.6
1.4
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
57
430
1.37
1.37
1.2
1.2
iu/ml
119.9
152.2
0.29
28
193
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
16
270
0.58
1.35
1.6
1.4
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
44
318
1.42
1.35
1.8
2.1
u/l
1335.9
3848.6
1.00
13
134
(3004588) Protein electrophoresis panel - Serum or Plasma
26
168
1.58
1.34
1.3
2.0
—
—
—
0
0
(3021447) Carbon dioxide [Partial pressure] in Venous blood
32
219
1.50
1.30
4.4
2.9
kpa
5.6
5.9
1.15
32
213
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
39
278
1.44
1.29
1.5
1.5
—
—
—
0
0
(3022948) Iron [Moles/volume] in Serum or Plasma
64
498
1.33
1.27
2.3
2.1
umol/l
15.4
13.9
0.76
57
463
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
18
288
0.61
1.25
1.6
1.5
—
—
—
0
0
(3012544) pH of Venous blood
32
221
1.48
1.25
3.9
2.9
—
—
—
0
0
(44813793)
8
36
2.24
1.25
1.5
1.0
—
—
—
0
0
(40761535) Cells panel - Urine sediment
36
255
1.45
1.24
4.4
3.1
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
59
458
1.33
1.20
1.9
1.9
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
68
539
1.31
1.20
3.2
3.1
ng/l
128.1
164.7
0.12
44
317
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
53
406
1.35
1.18
1.5
1.6
—
—
—
0
0
(3004789) Transferrin [Mass/volume] in Serum or Plasma
58
451
1.33
1.17
2.3
2.1
g/l
2.4
2.5
0.12
51
420
(3006442) Creatine [Moles/volume] in Serum or Plasma
0
33
0.00
1.16
0.0
1.3
—
65.8
—
0
5
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
0
34
0.00
1.16
0.0
1.2
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
5
20
2.52
1.15
2.0
2.2
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
25
167
1.53
1.15
1.5
1.5
—
—
—
0
0
(3022313) Gas panel - Capillary blood
5
113
0.44
1.14
1.8
3.3
—
—
—
0
0
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
18
111
1.65
1.13
2.4
2.2
%
1.6
1.1
0.71
18
111
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
27
185
1.49
1.11
1.9
1.7
—
—
—
0
0
(4027681)
7
31
2.28
1.10
1.1
1.2
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
88
729
1.26
1.10
3.5
3.5
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
97
814
1.24
1.09
2.0
2.0
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
59
466
1.31
1.08
3.3
2.4
e6/l
5.2
4.4
0.13
37
227
(3015171) Extractable nuclear Ab [Units/volume] in Serum
28
195
1.46
1.07
1.4
1.3
u/ml
2.1
0.9
—
6
15
(3044889) 12 lead EKG panel
272
2522
1.19
1.07
3.6
3.0
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
52
405
1.32
1.05
2.6
2.2
%
26.1
22.8
0.79
41
345
(3035320) C reactive protein [Mass/volume] in Body fluid
5
22
2.29
1.03
2.2
1.9
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
5
22
2.29
1.03
3.0
3.0
—
—
—
0
0
(3035285) Chloride [Moles/volume] in Venous blood
7
34
2.07
1.03
1.9
2.4
mmol/l
102.7
106.5
—
7
34
(3041354) Potassium [Moles/volume] in Venous blood
7
34
2.07
1.03
1.9
2.4
mmol/l
4.1
3.9
—
7
34
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
7
34
2.07
1.03
1.3
1.1
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
7
34
2.07
1.03
1.9
2.4
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
130
1132
1.21
1.02
6.5
5.6
inr
1.0
1.1
0.87
38
373
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
123
1066
1.21
1.01
1.9
1.6
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
5
23
2.19
0.98
1.0
1.0
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
5
23
2.19
0.98
1.0
1.0
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
5
23
2.19
0.98
1.0
1.1
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
0
29
0.00
0.98
0.0
1.6
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
69
565
1.26
0.96
2.4
2.2
ug/g
128.0
96.5
0.20
52
442
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
30
218
1.40
0.94
1.7
1.5
—
—
—
0
0
(3022096) Basophils/100 leukocytes in Blood
194
1762
1.17
0.94
6.3
5.4
%
0.7
0.7
0.23
179
1634
(3019060) Gas panel - Arterial blood
21
142
1.50
0.94
4.1
4.3
—
—
—
0
0
(3000991) Gas panel - Venous blood
26
184
1.44
0.94
5.8
6.7
—
—
—
0
0
(3019230) Fractional oxyhemoglobin in Venous blood
6
27
2.24
0.93
1.8
1.9
%
63.7
60.9
—
6
27
(3009508) Creatinine [Moles/volume] in Urine
79
935
0.81
0.92
4.0
2.9
mmol/l
6.8
7.5
0.78
71
790
(3023419) Bacteria identified in Sputum by Culture
6
28
2.16
0.92
7.3
2.7
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
8
42
1.92
0.89
1.3
2.1
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
8
42
1.92
0.89
2.0
2.0
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
205
1877
1.17
0.88
4.2
3.8
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
6
30
2.01
0.87
2.0
2.1
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
8
44
1.83
0.86
1.0
1.2
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
13
80
1.64
0.85
1.3
1.5
—
—
—
0
0
(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum
13
81
1.62
0.82
1.3
1.1
—
12.5
—
0
9
(3003396) Base excess in Arterial blood by calculation
35
269
1.33
0.80
4.5
6.3
mmol/l
1.7
1.3
0.29
28
210
(3041096) Erythrocytes [Presence] in Urine by Automated
129
1147
1.17
0.80
3.1
2.8
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
0
24
0.00
0.79
0.0
2.0
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
0
24
0.00
0.79
0.0
1.7
—
—
—
0
0
(3020717) Zinc [Moles/volume] in Serum or Plasma
0
24
0.00
0.79
0.0
1.2
—
26.5
—
0
24
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
0
26
0.00
0.78
0.0
1.5
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
0
26
0.00
0.78
0.0
1.5
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
0
26
0.00
0.78
0.0
1.5
—
—
—
0
0
(3017354) Segmented neutrophils/100 leukocytes in Blood
0
27
0.00
0.77
0.0
2.7
—
48.2
—
0
15
(1002224) Polysomnography panel
13
197
0.65
0.77
1.0
1.1
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
16
232
0.68
0.77
1.6
1.5
—
—
—
0
0
(3013115) Eosinophils [#/volume] in Blood
220
2042
1.15
0.76
6.1
5.6
e9/l
0.2
0.2
0.83
206
1832
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
22
158
1.41
0.76
1.6
1.5
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
390
3778
1.21
0.75
13.9
11.6
%
39.5
39.5
0.05
308
3023
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
59
491
1.23
0.74
1.6
1.5
%
1.4
1.3
0.30
53
443
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
8
136
0.58
0.74
1.8
1.7
%
94.0
96.6
—
8
127
(3014576) Chloride [Moles/volume] in Serum or Plasma
38
300
1.29
0.73
5.0
5.4
mmol/l
103.7
104.3
0.37
38
292
(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum
5
25
2.01
0.73
1.6
1.2
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
5
25
2.01
0.73
12.4
3.6
—
—
—
0
0
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
9
56
1.62
0.72
1.1
1.2
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
360
3471
1.17
0.69
15.1
13.0
%
13.4
13.5
0.83
354
3417
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
7
119
0.58
0.68
1.3
1.6
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
5
93
0.53
0.67
1.4
1.6
—
—
—
0
0
(40758558) Short blood count panel - Blood
111
989
1.16
0.67
5.7
6.3
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
16
225
0.70
0.67
1.6
1.4
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
7
43
1.64
0.67
1.4
1.4
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
7
44
1.60
0.65
2.1
2.1
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
68
583
1.20
0.65
1.8
2.0
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
16
223
0.71
0.64
1.6
1.4
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
16
112
1.44
0.64
1.3
1.3
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
5
29
1.73
0.64
1.0
1.0
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
5
29
1.73
0.64
1.6
1.4
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
104
926
1.16
0.64
1.6
1.8
mg/l
0.7
0.8
0.42
80
696
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
378
3884
0.85
0.63
3.7
3.8
mmol/l
4.8
4.9
0.20
366
3682
(3003740) Influenza virus B Ag [Presence] in Specimen
6
103
0.58
0.62
1.0
1.1
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
6
103
0.58
0.62
1.0
1.1
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
11
71
1.56
0.62
5.9
4.3
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
47
561
0.82
0.62
1.2
1.3
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
13
88
1.49
0.61
9.2
3.3
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
0
22
0.00
0.59
0.0
1.2
—
—
—
0
0
(4146454)
0
22
0.00
0.59
0.0
3.4
—
—
—
0
0
(3029396) Erythrocyte agglutination [Presence] in Blood
0
23
0.00
0.58
0.0
2.7
—
—
—
0
0
(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma
0
23
0.00
0.58
0.0
1.1
—
120.6
—
0
17
(4034850)
7
116
0.60
0.58
15.6
5.4
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
284
2711
1.12
0.58
4.4
4.0
—
—
—
0
0
(44790048)
6
35
1.72
0.58
1.5
1.3
—
—
—
0
0
(44806118)
6
35
1.72
0.58
1.5
1.3
—
—
—
0
0
(44790047)
6
35
1.72
0.58
1.5
1.3
—
—
—
0
0
(44790049)
6
35
1.72
0.58
1.5
1.3
—
—
—
0
0
(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)
6
36
1.68
0.57
1.2
1.1
—
1.1
—
0
14
(3000330) Specific gravity of Urine by Test strip
21
159
1.34
0.56
4.2
2.9
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
349
3378
1.14
0.55
4.5
4.4
pmol/l
14.4
14.4
0.07
331
3162
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
6
38
1.59
0.54
1.0
1.2
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
425
4175
1.23
0.54
9.6
8.9
u/l
24.9
23.8
0.28
412
4056
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
11
74
1.50
0.54
1.2
1.2
u/ml
164.0
245.0
—
6
47
(3021879) Hepatitis B virus core Ab [Presence] in Serum
42
351
1.22
0.54
1.8
1.4
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
157
1454
1.12
0.53
5.0
4.5
mmol/l
1.2
1.2
0.03
143
1329
(3020961) Endomysium IgA Ab [Titer] in Serum
29
233
1.26
0.52
1.1
1.1
—
195.0
—
0
6
(3027945) Reticulocytes/100 erythrocytes in Blood
33
270
1.24
0.51
1.9
2.8
%
1.8
1.8
0.03
33
240
(3026782) Osmolality of Urine
72
635
1.16
0.51
3.4
2.4
mosm/kgh2o
504.9
529.2
0.45
60
534
(40768443) Skin Pathology biopsy report
10
145
0.68
0.51
1.0
1.2
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
378
3870
0.87
0.51
3.7
3.7
mmol/l
1.5
1.6
0.96
360
3657
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
6
41
1.47
0.50
1.2
1.1
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
287
2754
1.11
0.50
2.9
2.8
u/l
40.6
35.6
0.50
273
2625
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
35
290
1.22
0.49
3.0
4.0
ug/l
14.4
8.2
0.33
26
228
(36304419) Bacteria [Presence] in Urine
99
897
1.13
0.48
4.2
2.5
—
—
—
0
0
(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
7
46
1.53
0.48
2.1
1.6
u/ml
2.4
100.8
—
7
38
(3019069) Monocytes/100 leukocytes in Blood
196
1847
1.11
0.48
6.5
5.5
%
8.1
8.0
0.28
183
1729
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
7
47
1.50
0.47
1.1
1.3
—
—
—
0
0
(4268621)
7
47
1.50
0.47
1.9
2.1
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
405
3970
1.17
0.47
12.4
10.7
mg/l
22.4
18.8
1.25
314
3011
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
23
182
1.28
0.47
1.4
2.0
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
7
48
1.47
0.47
1.4
1.4
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
60
526
1.16
0.47
1.7
1.7
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
11
77
1.44
0.46
1.7
1.2
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
5
85
0.58
0.45
1.2
1.3
—
—
—
0
0
(3006504) Eosinophils/100 leukocytes in Blood
195
1842
1.10
0.45
6.1
5.3
%
2.7
2.7
0.09
181
1712
(3024891) Influenza virus A+B Ag [Presence] in Specimen
9
128
0.70
0.44
1.2
1.1
—
—
—
0
0
(3019198) Lymphocytes [#/volume] in Blood
213
2024
1.10
0.43
6.2
5.3
e9/l
1.9
2.0
0.44
197
1821
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
8
56
1.44
0.42
1.4
1.9
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
125
1158
1.11
0.42
3.1
2.9
ng/l
89.8
58.0
0.17
52
602
(3013826) Glucose [Moles/volume] in Serum or Plasma
210
1996
1.10
0.42
3.6
3.8
mmol/l
6.5
6.3
0.37
192
1805
(3003694) ABO and Rh group [Type] in Blood
118
1274
0.90
0.42
1.8
1.6
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
0
15
0.00
0.41
0.0
3.8
—
—
—
0
0
(3000492) Spirometry study
42
362
1.18
0.41
1.7
1.3
—
—
—
0
0
(3002030) Lymphocytes/100 leukocytes in Blood
201
1909
1.09
0.41
6.0
5.4
%
30.1
29.5
0.34
188
1777
(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
0
16
0.00
0.41
0.0
3.4
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
8
59
1.36
0.41
1.0
1.1
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
235
2248
1.09
0.41
8.1
8.3
e9/l
3.9
3.9
0.13
214
1985
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
16
123
1.31
0.41
1.3
1.1
—
—
—
0
0
(21494434) Karyotype in Bone marrow
0
17
0.00
0.40
0.0
1.1
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
385
3924
0.89
0.40
4.1
4.1
mmol/l
2.9
2.9
0.05
363
3701
(3002256) Pathology report gross observation
58
514
1.15
0.40
1.3
1.2
—
—
—
0
0
(43055514) Macroprolactin [Presence] in Serum or Plasma
0
18
0.00
0.40
0.0
1.9
—
—
—
0
0
(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma
0
18
0.00
0.40
0.0
1.2
—
30.8
—
0
18
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
0
19
0.00
0.39
0.0
1.4
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
0
19
0.00
0.39
0.0
1.4
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
0
19
0.00
0.39
0.0
1.4
—
—
—
0
0
(3016750) Collection duration of Urine
0
19
0.00
0.39
0.0
2.3
—
506.2
—
0
13
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
0
19
0.00
0.39
0.0
1.4
—
—
—
0
0
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
0
19
0.00
0.39
0.0
1.1
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
29
344
0.83
0.39
1.1
1.4
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
11
80
1.38
0.38
1.1
1.2
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
10
136
0.73
0.38
1.3
1.2
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
5
37
1.36
0.37
1.0
1.1
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
10
72
1.40
0.37
1.8
2.0
—
—
—
0
0
(3022145) Colonoscopy Study observation
48
423
1.15
0.37
1.4
1.3
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
72
653
1.12
0.36
2.9
3.0
ng/l
468.3
708.2
1.22
54
543
(3022621) pH of Urine by Test strip
28
236
1.20
0.36
1.7
2.3
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
5
80
0.62
0.35
1.2
1.1
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
60
539
1.13
0.35
1.7
1.6
nmol/l
1292.9
1189.7
0.38
54
410
(3030467) Casts [#/volume] in Urine by Automated count
96
887
1.10
0.35
4.4
2.6
e6/l
0.4
0.3
0.06
75
648
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
10
73
1.38
0.35
1.1
1.1
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
6
45
1.34
0.34
1.2
1.7
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
6
45
1.34
0.34
1.0
1.1
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
101
939
1.10
0.33
1.8
1.7
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
61
552
1.12
0.32
1.8
1.5
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
10
132
0.75
0.32
1.3
1.1
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
16
128
1.26
0.32
1.4
1.3
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
11
83
1.33
0.32
1.4
1.1
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
11
83
1.33
0.32
1.7
2.0
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
82
888
0.91
0.32
1.9
1.9
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
67
733
0.90
0.32
1.6
1.7
—
—
—
0
0
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
7
52
1.35
0.31
1.4
1.4
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
28
240
1.18
0.31
1.7
1.6
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
7
54
1.30
0.30
1.0
1.3
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
75
690
1.10
0.30
3.4
2.3
e6/l
9.8
9.1
0.08
61
600
(3047007) Chlamydophila sp Ab [Presence] in Serum
10
75
1.34
0.30
1.3
1.2
—
—
—
0
0
(3030981) Hyaline casts [#/volume] in Urine by Automated count
12
152
0.78
0.30
1.1
2.5
e6/l
0.8
0.1
0.52
12
145
(3018010) Neutrophils/100 leukocytes in Blood
197
1891
1.07
0.29
6.1
5.1
%
56.1
56.5
0.22
184
1771
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
7
56
1.25
0.29
1.6
4.4
—
3.3
—
0
7
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
7
57
1.23
0.29
1.7
4.4
mg/l
36.8
24.4
—
7
44
(3034860) Kappa light chains.free [Mass/volume] in Serum
7
57
1.23
0.29
1.6
4.4
mg/l
55.5
32.2
—
7
45
(3002582) Erythrocytes [#/volume] in Urine
104
975
1.09
0.29
3.9
2.7
e6/l
23.1
65.3
1.49
80
722
(40761536) Microorganisms panel - Urine sediment
39
346
1.14
0.29
4.1
3.3
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
11
85
1.30
0.28
1.5
1.7
—
—
—
0
0
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
19
226
0.83
0.28
1.2
1.7
mg/l
3.3
2.5
0.62
14
148
(3023520) Reticulocytes [#/volume] in Blood
21
177
1.20
0.28
1.9
2.9
e9/l
65.9
76.1
0.68
16
132
(42870588) Differential panel, method unspecified - Blood
128
1212
1.08
0.28
6.3
5.3
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
9
120
0.75
0.27
2.3
1.8
—
—
—
0
0
(3001604) Monocytes [#/volume] in Blood
203
1956
1.07
0.27
6.0
5.3
e9/l
0.5
0.5
0.02
184
1728
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
18
150
1.21
0.26
2.3
2.1
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
21
178
1.19
0.26
1.3
1.6
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
5
72
0.69
0.26
2.8
1.4
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
365
3709
0.92
0.26
3.2
3.4
mmol/l
1.2
1.2
0.60
347
3491
(3035941) MCH [Entitic mass]
442
4450
0.84
0.26
18.0
16.1
pg
30.2
30.1
0.75
437
4404
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
368
3737
0.92
0.25
3.8
3.8
mmol/l
5.6
5.7
0.10
342
3489
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
177
1702
1.06
0.25
2.4
2.2
nmol/l
76.0
76.3
0.05
163
1569
(3021589) Normoblasts [#/volume] in Blood
165
1715
0.94
0.23
8.9
7.7
e9/l
0.0
0.0
1.28
140
1416
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
10
125
0.80
0.23
2.2
1.9
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
10
125
0.80
0.23
1.1
1.1
—
—
—
0
0
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
5
39
1.29
0.23
1.0
1.1
u/l
14.8
16.2
—
5
32
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
5
39
1.29
0.23
1.0
1.2
u/l
39.8
59.4
—
5
25
(3006315) Basophils [#/volume] in Blood
203
1966
1.06
0.22
6.1
5.3
e9/l
0.0
0.0
0.37
182
1731
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
320
3140
1.06
0.22
3.6
3.7
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
5
42
1.19
0.21
1.4
1.1
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
5
42
1.19
0.21
1.4
1.1
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
11
0.00
0.21
0.0
2.4
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
0
11
0.00
0.21
0.0
1.6
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
0
11
0.00
0.21
0.0
1.6
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
0
11
0.00
0.21
0.0
10.5
—
—
—
0
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
11
0.00
0.21
0.0
2.4
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
0
11
0.00
0.21
0.0
1.6
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
0
10
0.00
0.21
0.0
2.6
—
—
—
0
0
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
0
10
0.00
0.21
0.0
1.3
—
—
—
0
0
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
10
0.00
0.21
0.0
1.3
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
0
10
0.00
0.21
0.0
7.7
—
—
—
0
0
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(44806071)
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(40760435) Tropomyosin IgE Ab [Units/volume] in Serum
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
152
1579
0.94
0.21
2.3
2.4
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(3035880) pH of Pleural fluid
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
(3023709) Somatotropin [Mass/volume] in Serum or Plasma
0
12
0.00
0.21
0.0
2.2
—
1.4
—
0
12
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
0
13
0.00
0.21
0.0
2.5
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
442
4446
0.86
0.20
18.1
16.3
e9/l
267.0
266.6
0.04
435
4364
(3021960) Folate [Moles/volume] in Serum or Plasma
79
744
1.07
0.20
1.5
1.4
nmol/l
24.1
22.0
0.56
69
644
(40765089) Chromosome analysis panel - Blood by G-banded
0
14
0.00
0.20
0.0
1.0
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
0
14
0.00
0.20
0.0
1.4
—
—
—
0
0
(3000012) Reticulocyte production index
0
14
0.00
0.20
0.0
1.4
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
17
146
1.17
0.19
1.5
1.6
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
80
846
0.93
0.19
4.6
3.8
mg/mmol
10.6
7.2
0.37
52
499
(1616796) Gas panel - Central venous blood
6
51
1.18
0.19
1.3
2.1
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
15
175
0.85
0.19
1.3
1.8
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
10
81
1.24
0.19
1.2
1.6
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
337
3420
0.95
0.19
5.0
4.6
mmol/mol
38.0
38.1
0.11
319
3226
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
113
1082
1.06
0.18
1.2
1.3
u/ml
0.6
1.9
1.66
30
298
(3014765) Yersinia sp identified in Stool by Organism specific culture
11
132
0.83
0.18
1.3
1.1
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
44
474
0.92
0.17
1.3
1.6
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
20
225
0.88
0.16
1.8
1.3
miu/ml
266.1
246.7
—
9
114
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
25
277
0.90
0.16
2.5
2.2
ml/min/173m2
85.7
77.6
—
6
107
(3010813) Leukocytes [#/volume] in Blood
443
4452
0.87
0.16
18.1
16.3
e9/l
6.7
6.6
0.44
433
4353
(3043409) Potassium [Moles/volume] in Arterial blood
6
79
0.76
0.15
6.8
3.1
mmol/l
3.4
3.7
—
6
70
(4094501)
6
80
0.75
0.15
1.3
1.0
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
9
78
1.16
0.15
1.2
1.2
—
—
—
0
0
(3000963) Hemoglobin [Mass/volume] in Blood
443
4451
0.88
0.15
18.1
16.3
g/l
132.5
132.9
0.33
438
4406
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
9
81
1.11
0.15
1.1
1.3
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
7
87
0.80
0.14
1.9
3.9
%
59.1
58.8
—
7
87
(3026361) Erythrocytes [#/volume] in Blood
443
4450
0.88
0.14
18.1
16.2
e12/l
4.4
4.4
1.35
434
4357
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
12
103
1.17
0.14
7.2
2.8
mmol/l
24.0
24.2
0.16
12
96
(3020891) Body temperature
8
96
0.83
0.14
7.4
3.7
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
80
835
0.95
0.13
2.2
2.1
umol/l
298.4
5971.0
3.68
67
745
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
131
1350
0.96
0.13
1.8
1.8
pmol/l
90.7
99.2
1.22
69
702
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
11
94
1.17
0.13
1.1
1.3
—
1.1
—
0
6
(3024731) MCV [Entitic volume]
443
4449
0.89
0.13
18.0
16.2
fl
90.7
90.4
0.80
438
4404
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
62
591
1.06
0.12
1.4
1.4
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
20
181
1.11
0.12
1.7
1.7
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
124
1205
1.04
0.12
2.5
3.1
mmol/l
2.3
2.4
0.89
117
1088
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
76
732
1.05
0.11
1.9
1.9
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
12
106
1.14
0.10
2.9
3.2
g/l
0.1
0.3
—
6
34
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
5
45
1.11
0.10
1.4
1.1
—
—
—
0
0
(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight
5
45
1.11
0.10
1.2
1.3
—
—
—
0
0
(4281824)
5
46
1.09
0.09
1.2
1.1
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
213
2097
1.03
0.09
3.0
2.8
ug/l
87.8
68.0
1.08
206
1982
(3044290) Cell count panel - Cerebral spinal fluid
10
87
1.15
0.09
1.0
1.9
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
5
47
1.06
0.09
1.4
1.7
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
6
55
1.09
0.09
1.3
1.9
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
30
318
0.94
0.08
2.3
2.8
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
44
460
0.95
0.08
1.6
1.5
—
—
—
0
0
(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma
5
60
0.83
0.08
1.0
1.2
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
7
64
1.10
0.08
1.3
1.3
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
7
64
1.10
0.08
1.3
1.3
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
116
1186
0.97
0.08
2.0
2.0
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
32
303
1.06
0.08
1.2
1.2
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
7
67
1.05
0.08
1.4
1.3
—
—
—
0
0
(4306422)
6
72
0.83
0.07
2.0
1.1
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
6
73
0.82
0.07
1.3
1.4
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
8
74
1.08
0.07
1.4
1.4
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
57
590
0.96
0.07
2.2
2.4
mmol/l
2.4
2.4
1.04
48
525
(40768797) Stomach Pathology biopsy report
53
511
1.04
0.07
1.2
1.1
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
8
77
1.04
0.07
1.4
1.4
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
7
84
0.83
0.07
1.9
3.5
e9/l
4.0
4.5
—
7
84
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
9
85
1.06
0.07
1.0
1.3
—
—
—
0
0
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
15
139
1.08
0.05
1.1
1.2
—
1.9
—
0
7
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
15
139
1.08
0.05
1.3
1.3
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
100
982
1.02
0.05
1.8
1.6
mmol/l
1.3
1.4
0.10
89
855
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
31
323
0.96
0.05
3.8
2.1
u/l
38.2
31.4
0.56
25
270
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
27
258
1.05
0.05
2.6
3.6
mmol/l
1.2
1.2
0.97
22
224
(3012516) Albumin [Mass/volume] in Urine
79
806
0.98
0.04
4.1
3.1
mg/l
72.7
221.0
0.57
54
491
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
13
121
1.08
0.03
4.9
7.4
mmol/l
23.4
24.1
0.67
13
115
(3025941) Bacteria identified in Stool by Culture
26
250
1.04
0.03
1.3
1.2
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
27
280
0.96
0.03
1.9
1.4
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
420
4210
0.97
0.03
11.3
10.1
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
103
1018
1.02
0.02
3.4
4.1
—
—
—
0
0
(3014111) Lactate [Moles/volume] in Serum or Plasma
23
222
1.04
0.02
4.3
5.3
mmol/l
1.2
1.2
0.06
23
212
(3007164) IgA [Mass/volume] in Serum or Plasma
91
920
0.99
0.02
1.5
1.4
g/l
2.7
2.2
1.59
57
584
(3018095) Leukocytes [#/volume] in Urine
125
1240
1.01
0.02
4.4
3.2
e6/l
62.1
62.7
0.01
90
804
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
41
402
1.02
0.01
5.9
4.8
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
44
432
1.02
0.01
1.4
1.3
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
17
163
1.04
0.01
2.5
2.3
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
26
267
0.97
0.01
1.1
1.0
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
18
186
0.97
0.00
1.2
1.3
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
385
3856
0.99
0.00
5.2
5.1
mu/l
1.7
2.0
0.54
365
3633
(46235355) HIV 1 and 2 tests - Meaningful Use set
112
1114
1.01
0.00
2.1
1.9
—
—
—
0
0
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
10
97
1.03
0.00
1.1
1.4
mmol/l
3.3
3.7
—
10
88
(3020779) Urea [Moles/volume] in Serum or Plasma
19
194
0.98
0.00
8.4
7.1
mmol/l
8.5
7.5
0.24
19
184
(3023103) Potassium [Moles/volume] in Serum or Plasma
390
3902
1.00
0.00
12.8
10.8
mmol/l
3.9
3.9
0.22
381
3783
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
89
892
1.00
0.00
2.3
2.0
mg/l
2.7
2.8
0.32
81
771
(3050129) First trimester maternal screen panel - Serum or Plasma
31
309
1.00
0.00
1.4
1.5
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
37
371
1.00
0.00
1.1
1.2
—
—
—
0
0
(3019550) Sodium [Moles/volume] in Serum or Plasma
389
3887
1.00
0.00
12.7
10.8
mmol/l
139.4
139.7
1.24
380
3779
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
5
58
0.86
0.00
1.0
1.2
—
—
—
0
0
(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay
5
55
0.91
0.00
2.8
3.5
u/ml
15.7
94.4
—
5
55
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
6
65
0.92
0.00
1.3
1.8
—
—
—
0
0
(4133840)
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
5
51
0.98
0.00
1.2
1.4
—
—
—
0
0
(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3004446) Plasmodium sp identified in Blood by Light microscopy
0
6
0.00
0.00
0.0
2.7
—
—
—
0
0
(37021550) Renin [Units/volume] in Plasma --upright
0
9
0.00
0.00
0.0
1.1
—
132.7
—
0
9
(3044009) aPTT.lupus sensitive (LA screen)
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
0
9
0.00
0.00
0.0
2.0
—
—
—
0
0
(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture
0
7
0.00
0.00
0.0
1.9
—
—
—
0
0
(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3032057) Clostridioides difficile [Presence] in Stool
0
9
0.00
0.00
0.0
2.1
—
—
—
0
0
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
0
7
0.00
0.00
0.0
2.9
—
—
—
0
0
(3008898) HLA-B27 [Presence]
23
230
1.00
0.00
1.1
1.1
—
—
—
0
0
(3001556) Androgen free Index in Serum or Plasma
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture
0
6
0.00
0.00
0.0
2.0
—
—
—
0
0
(3004269) Kappa light chains [Mass/time] in 24 hour Urine
0
6
0.00
0.00
0.0
4.2
—
—
—
0
0
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3035457) Cefaclor IgE Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3013293) Extractable nuclear Ab [Presence] in Serum
0
8
0.00
0.00
0.0
2.0
—
—
—
0
0
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
6
60
1.00
0.00
2.2
2.7
—
—
—
0
0
(3020356) Listeria sp identified in Specimen by Organism specific culture
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3019174) dRVVT (LA screen)
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3010937) Rubella virus Ab [Presence] in Serum
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
7
78
0.90
0.00
1.0
1.1
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
7
69
1.01
0.00
1.4
1.2
—
—
—
0
0
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
5
49
1.02
0.00
1.2
1.1
—
—
—
0
0
(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3005011) Chlamydia sp Ab [Titer] in Serum
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
0
8
0.00
0.00
0.0
1.5
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
8
80
1.00
0.00
1.5
1.2
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
5
51
0.98
0.00
1.2
1.1
—
—
—
0
0
(3000285) Sodium [Moles/volume] in Blood
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3017509) Phencyclidine [Presence] in Urine
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3020393) Adenovirus Ag [Presence] in Stool
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
(3051101) Glucose [Moles/volume] in Cord blood
0
5
0.00
-0.00
0.0
2.8
—
—
—
0
0
(3001186) Copper [Moles/volume] in Serum or Plasma
0
5
0.00
-0.00
0.0
1.2
—
16.9
—
0
5
(3022689) Creatine [Moles/volume] in Urine
0
5
0.00
-0.00
0.0
1.4
—
—
—
0
0
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
0
5
0.00
-0.00
0.0
1.4
—
—
—
0
0
(3002067) Lambda light chains [Mass/time] in 24 hour Urine
0
5
0.00
-0.00
0.0
4.8
—
—
—
0
0
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
0
5
0.00
-0.00
0.0
1.8
—
—
—
0
0
(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood
0
5
0.00
-0.00
0.0
2.0
—
1.2
—
0
5
(3051339) Copper [Moles/volume] in Blood
0
5
0.00
-0.00
0.0
1.2
—
15.9
—
0
5
(3044007) Cell count panel - Peritoneal fluid
0
5
0.00
-0.00
0.0
2.0
—
—
—
0
0
(21494262) English walnut recombinant (rJug r) 3 IgE Ab [Units/volume] in Serum
0
5
0.00
-0.00
0.0
1.0
—
0.0
—
0
5
(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
5
0.00
-0.00
0.0
1.4
—
—
—
0
0
(3012984) Norclozapine [Mass/volume] in Serum or Plasma
0
5
0.00
-0.00
0.0
6.6
—
—
—
0
0

Mortality – FinRegistry

↥

Association

Association between endpoint N14_FEMALE_GENITAL_DYSPLASIA_NOS and mortality.

Females

Parameter HR [95% CI] p-value
N14_FEMALE_GENITAL_DYSPLASIA_NOS 1.288 [1.06, 1.57] 0.012
Birth year 0.995 [0.99, 1.0] 0.254

During the follow-up period (1.1.1998 — 31.12.2019), 177 out of 2382 females with N14_FEMALE_GENITAL_DYSPLASIA_NOS died.

Males

No data

Mortality risk

Mortality risk for people of age

years, who have N14_FEMALE_GENITAL_DYSPLASIA_NOS.

N-year risk Females Males
1 0.127% No data
5 0.817% No data
10 2.041% No data
15 3.893% No data
20 6.818% No data

Relationships between endpoints

↥

Index endpoint: N14_FEMALE_GENITAL_DYSPLASIA_NOS – Dysplastic lesion of unknown severity in the cervix uteri, vagina or vulva

GWS hits: -

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data